WINTON GROUP Ltd Purchases 3,774 Shares of Addus Homecare Co. (NASDAQ:ADUS)

WINTON GROUP Ltd grew its position in shares of Addus Homecare Co. (NASDAQ:ADUS) by 106.7% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 7,311 shares of the company’s stock after buying an additional 3,774 shares during the quarter. WINTON GROUP Ltd owned approximately 0.06% of Addus Homecare worth $548,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently modified their holdings of ADUS. Pier Capital LLC acquired a new position in shares of Addus Homecare during the first quarter worth approximately $9,015,000. TimesSquare Capital Management LLC lifted its position in shares of Addus Homecare by 17.0% during the first quarter. TimesSquare Capital Management LLC now owns 882,730 shares of the company’s stock worth $56,133,000 after purchasing an additional 128,330 shares in the last quarter. Bank of New York Mellon Corp lifted its position in shares of Addus Homecare by 117.8% during the fourth quarter. Bank of New York Mellon Corp now owns 120,855 shares of the company’s stock worth $8,204,000 after purchasing an additional 65,356 shares in the last quarter. Emerald Mutual Fund Advisers Trust acquired a new position in shares of Addus Homecare during the first quarter worth approximately $4,151,000. Finally, Emerald Advisers LLC acquired a new position in shares of Addus Homecare during the first quarter worth approximately $4,106,000. 99.01% of the stock is currently owned by hedge funds and other institutional investors.

In other Addus Homecare news, CFO Brian Poff sold 20,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 14th. The shares were sold at an average price of $70.57, for a total value of $1,411,400.00. Following the completion of the sale, the chief financial officer now owns 38,241 shares of the company’s stock, valued at $2,698,667.37. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Mark L. First sold 440,000 shares of the company’s stock in a transaction that occurred on Tuesday, June 11th. The shares were sold at an average price of $74.08, for a total transaction of $32,595,200.00. Following the completion of the sale, the director now directly owns 19,151 shares of the company’s stock, valued at approximately $1,418,706.08. The disclosure for this sale can be found here. Insiders sold 460,814 shares of company stock worth $34,061,919 over the last 90 days. 20.10% of the stock is currently owned by company insiders.

NASDAQ ADUS traded up $0.13 during trading hours on Wednesday, hitting $82.35. The company’s stock had a trading volume of 2,302 shares, compared to its average volume of 80,549. The stock has a fifty day moving average of $76.07. Addus Homecare Co. has a twelve month low of $56.75 and a twelve month high of $82.39. The firm has a market cap of $1.06 billion, a price-to-earnings ratio of 48.70, a P/E/G ratio of 2.47 and a beta of -0.09. The company has a quick ratio of 2.87, a current ratio of 2.87 and a debt-to-equity ratio of 0.10.

Addus Homecare (NASDAQ:ADUS) last announced its quarterly earnings data on Monday, May 6th. The company reported $0.44 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.40 by $0.04. Addus Homecare had a net margin of 3.20% and a return on equity of 8.95%. The business had revenue of $139.25 million for the quarter, compared to analyst estimates of $139.37 million. As a group, sell-side analysts anticipate that Addus Homecare Co. will post 2.11 EPS for the current year.

ADUS has been the topic of a number of research reports. Zacks Investment Research upgraded shares of Gerdau from a “sell” rating to a “hold” rating in a research report on Monday, May 13th. BMO Capital Markets initiated coverage on shares of Encompass Health in a research report on Thursday, June 27th. They set an “outperform” rating and a $72.00 target price on the stock. Raymond James initiated coverage on shares of Adverum Biotechnologies in a research report on Thursday, June 13th. They set a “market perform” rating on the stock. ValuEngine upgraded shares of XPO Logistics from a “strong sell” rating to a “sell” rating in a research report on Thursday, April 4th. Finally, BidaskClub lowered shares of Woodward, Inc.Common Stock from a “strong-buy” rating to a “buy” rating in a research report on Saturday. One equities research analyst has rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $77.88.

Addus Homecare Profile

Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates in three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living.

See Also: What is systematic risk?

Institutional Ownership by Quarter for Addus Homecare (NASDAQ:ADUS)

Receive News & Ratings for Addus Homecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus Homecare and related companies with MarketBeat.com's FREE daily email newsletter.